{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:25:50Z","timestamp":1785583550445,"version":"3.56.0"},"reference-count":175,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emergency Medicine Clinics of North America"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.emc.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,10,15]],"date-time":"2013-10-15T04:00:33Z","timestamp":1381809633000},"page":"1-28","source":"Crossref","is-referenced-by-count":93,"title":["Emerging Drugs of Abuse"],"prefix":"10.1016","volume":"32","author":[{"given":"Michael E.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Aks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.emc.2013.09.001_bib1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s13181-013-0299-6","article-title":"Leveraging social networks for toxicovigilance","volume":"9","author":"Chary","year":"2013","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pnpbp.2012.07.011","article-title":"Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project","volume":"39","author":"Deluca","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.emc.2013.09.001_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/15563650.2011.645952","article-title":"\u201cLegal highs\u201d \u2013 novel and emerging psychoactive drugs: a chemical overview for the toxicologist","volume":"50","author":"Gibbons","year":"2012","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-013-8370-2","article-title":"Alternative drugs of abuse","author":"Sutter","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.emc.2013.09.001_bib5","unstructured":"Aleksander I. Molly: pure but not so simple. 2013. Available at: http:\/\/www.nytimes.com\/2013\/06\/23\/fashion\/molly-pure-but-not-so-simple.html?pagewanted=1&_r=1&hpw&. Accessed June 24, 2013."},{"key":"10.1016\/j.emc.2013.09.001_bib6","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMp1011512","article-title":"The flood of opioids: a rising tide of deaths","volume":"363","author":"Okie","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.emc.2013.09.001_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/02791072.2013.764232","article-title":"Diversion of benzodiazepines through healthcare sources","volume":"45","author":"Ibanez","year":"2013","journal-title":"J\u00a0Psychoactive Drugs"},{"key":"10.1016\/j.emc.2013.09.001_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1744-6171.2012.00322.x","article-title":"Exploring the relationship among ADHD, stimulants, and substance abuse","volume":"25","author":"Nelson","year":"2012","journal-title":"J\u00a0Child Adolesc Psychiatr Nurs"},{"key":"10.1016\/j.emc.2013.09.001_bib9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1526-4637.2011.01062.x","article-title":"Prescription drug monitoring programs and death rates from drug overdose","volume":"12","author":"Paulozzi","year":"2011","journal-title":"Pain Med"},{"key":"10.1016\/j.emc.2013.09.001_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.36076\/ppj.2007\/10\/399","article-title":"National drug control policy and prescription drug abuse: facts and fallacies","volume":"10","author":"Manchikanti","year":"2007","journal-title":"Pain Physician"},{"key":"10.1016\/j.emc.2013.09.001_bib11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2105\/AJPH.2012.300962","article-title":"Over-the-counter and out-of-control: legal strategies to protect youths from abusing products for weight control","volume":"103","author":"Pomeranz","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1016\/j.emc.2013.09.001_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1521-0391.2013.00311.x","article-title":"Performance-enhancing drugs on the web: a growing public-health issue","volume":"22","author":"Brennan","year":"2013","journal-title":"Am J Addict"},{"key":"10.1016\/j.emc.2013.09.001_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/dta.1441","article-title":"Annual banned-substance review: analytical approaches in human sports drug testing","volume":"5","author":"Thevis","year":"2013","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.emc.2013.09.001_bib14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3109\/15563650.2012.740637","article-title":"Melanotan II injection resulting in systemic toxicity and rhabdomyolysis","volume":"50","author":"Nelson","year":"2012","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib15","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3109\/15563650.2011.617310","article-title":"Methoxetamine: a novel ketamine analog and growing health-care concern","volume":"49","author":"Ward","year":"2011","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.drugpo.2013.05.009","article-title":"Krokodil and other home-produced drugs for injection: a perspective from Ukraine","volume":"24","author":"Booth","year":"2013","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.emc.2013.09.001_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MOP.0b013e3283506827","article-title":"Toxicity of energy drinks","volume":"24","author":"Wolk","year":"2012","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.emc.2013.09.001_bib18","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/j.1360-0443.1996.tb02264.x","article-title":"Cannabis: pharmacology and toxicology in animals and humans","volume":"91","author":"Adams","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.emc.2013.09.001_bib19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1521-0391.2012.00240.x","article-title":"\u201cSpice\u201d and \u201cK2\u201d herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans","volume":"21","author":"Gunderson","year":"2012","journal-title":"Am J Addict"},{"key":"10.1016\/j.emc.2013.09.001_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pnpbp.2012.04.017","article-title":"Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids","volume":"39","author":"Seely","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.emc.2013.09.001_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/mi.11.1.6","article-title":"Marijuana-based drugs: innovative therapeutics or designer drugs of abuse","volume":"11","author":"Seely","year":"2011","journal-title":"Mol Interv"},{"key":"10.1016\/j.emc.2013.09.001_bib22","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/jms.1558","article-title":"Spice and other herbal blends: harmless incense or cannabinoid designer drugs?","volume":"44","author":"Auw\u00e4rter","year":"2009","journal-title":"J\u00a0Mass Spectrom"},{"key":"10.1016\/j.emc.2013.09.001_bib23","series-title":"EMCDDA 2009 thematic paper \u2013 understanding the \u2018Spice\u2019 phenomenon","author":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)","year":"2009"},{"key":"10.1016\/j.emc.2013.09.001_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.toxlet.2010.06.002","article-title":"Spice drugs as a new trend: mode of action, identification and legislation","volume":"197","author":"Vardakou","year":"2010","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.emc.2013.09.001_bib25","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Synthetic cannabinoids and \u2018Spice.\u2019 Available at: http:\/\/www.emcdda.europa.eu\/publications\/drug-profiles\/synthetic-cannabinoids. Accessed September 2, 2013."},{"key":"10.1016\/j.emc.2013.09.001_bib26","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1002\/j.1552-4604.1981.tb02576.x","article-title":"Nabilone: an effective antiemetic in patients receiving cancer chemotherapy","volume":"21","author":"Einhorn","year":"1981","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.emc.2013.09.001_bib27","unstructured":"United States Adopted Names Council: Statement on a nonprioprietary name. Available at: http:\/\/www.ama-assn.org\/ama1\/pub\/upload\/mm\/365\/nabiximols.pdf. Accessed June 4, 2013."},{"key":"10.1016\/j.emc.2013.09.001_bib28","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0022-3565(25)33364-1","article-title":"Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol","volume":"223","author":"Weissman","year":"1982","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.emc.2013.09.001_bib29","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1021\/jm00107a034","article-title":"Antinociceptive (aminoalkyl)indoles","volume":"34","author":"Bell","year":"1991","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.emc.2013.09.001_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s13181-011-0202-2","article-title":"Here today, gone tomorrow\u2026 and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), Kratom, Salvia divinorum, methoxetamine, and piperazines","volume":"8","author":"Rosenbaum","year":"2012","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0960-894X(01)80155-4","article-title":"Design, synthesis and pharmacology of cannabimimetic indoles","volume":"4","author":"Huffman","year":"1994","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.emc.2013.09.001_bib32","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1021\/jm960394y","article-title":"Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor","volume":"39","author":"Huffman","year":"1996","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.emc.2013.09.001_bib33","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0022-3565(24)37496-8","article-title":"Structure-activity relationships of indole- and pyrrole-derived cannabinoids","volume":"285","author":"Wiley","year":"1998","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.emc.2013.09.001_bib34","series-title":"The cannabinoid receptors, 1","first-page":"49","article-title":"Cannabimimetic indoles, pyrroles, and indenes: structure-activity relationships and receptor interactions","author":"Huffman","year":"2009"},{"key":"10.1016\/j.emc.2013.09.001_bib35","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1476-5381.2009.00582.x","article-title":"JWH018, a common constituent of \u2018Spice\u2019 herbal blends, is a potent and efficacious cannabinoid CB1 receptor agonist","volume":"160","author":"Atwood","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.emc.2013.09.001_bib36","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3109\/15563650.2011.609822","article-title":"Severe toxicity following synthetic cannabinoid ingestion","volume":"49","author":"Lapoint","year":"2011","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jpeds.2012.12.056","article-title":"Exposure to bath salts and synthetic tetrahydrocannabinol from 2009 to 2012 in the United States","volume":"163","author":"Wood","year":"2013","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.emc.2013.09.001_bib38","unstructured":"Schedules of controlled substances: temporary placement of five synthetic cannabinoids into schedule I [FR Doc No: 11075\u201311078]. Drug Enforcement Administration (DEA). Available at: http:\/\/www.deadiversion.usdoj.gov\/fed_regs\/rules\/2011\/fr0301.htm. Accessed June 5, 2013."},{"key":"10.1016\/j.emc.2013.09.001_bib39","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1021\/ac2005636","article-title":"Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine","volume":"83","author":"Moran","year":"2011","journal-title":"Anal Chem"},{"key":"10.1016\/j.emc.2013.09.001_bib40","series-title":"Monitoring the future national results on drug use: 2012 overview, key findings on adolescent drug use","author":"Johnston","year":"2013"},{"key":"10.1016\/j.emc.2013.09.001_bib41","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/jat\/bks066","article-title":"Prevalence of synthetic cannabinoids in U.S. athletes: initial findings","volume":"36","author":"Heltsley","year":"2012","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib42","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.annemergmed.2012.03.007","article-title":"A\u00a0characterization of synthetic cannabinoid exposures reported to the national poison data system in 2010","volume":"60","author":"Hoyte","year":"2012","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.emc.2013.09.001_bib43","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1177\/0960327111421945","article-title":"Synthetic cannabinoid and marijuana exposures reported to poison centers","volume":"31","author":"Forrester","year":"2012","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.drugalcdep.2012.12.011","article-title":"Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample","volume":"131","author":"Winstock","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.emc.2013.09.001_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5811\/westjem.2013.1.14496","article-title":"Emergency physicians\u2019 knowledge of cannabinoid designer drugs","volume":"14","author":"Lank","year":"2013","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.emc.2013.09.001_bib46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0301-0082(98)00087-2","article-title":"The effects of cannabinoids on the brain","volume":"58","author":"Ameri","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.emc.2013.09.001_bib47","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2174\/092986710790980050","article-title":"Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists","volume":"17","author":"Pertwee","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.emc.2013.09.001_bib48","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.forsciint.2011.04.010","article-title":"A\u00a0preliminary investigation on the distribution of cannabinoids in man","volume":"210","author":"Gronewold","year":"2011","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.emc.2013.09.001_bib49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/bip.10424","article-title":"Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction","volume":"71","author":"Shim","year":"2003","journal-title":"Biopolymers"},{"key":"10.1016\/j.emc.2013.09.001_bib50","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.jchromb.2010.03.016","article-title":"Sensitive and rapid quantification of the\u00a0cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry","volume":"878","author":"Teske","year":"2010","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.emc.2013.09.001_bib51","doi-asserted-by":"crossref","first-page":"e21917","DOI":"10.1371\/journal.pone.0021917","article-title":"Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in\u00a0vitro and in\u00a0vivo cannabinoid 1 receptor affinity and activity","volume":"6","author":"Brents","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.emc.2013.09.001_bib52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.taap.2013.03.012","article-title":"Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors","volume":"269","author":"Rajasekaran","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.emc.2013.09.001_bib53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jadohealth.2011.08.002","article-title":"Synthetic cannabinoid use: a case series of adolescents","volume":"49","author":"Castellanos","year":"2011","journal-title":"J\u00a0Adolesc Health"},{"key":"10.1016\/j.emc.2013.09.001_bib54","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1176\/appi.ajp.2011.11010176","article-title":"Psychosis associated with synthetic cannabinoid agonists: a case series","volume":"168","author":"Hurst","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.emc.2013.09.001_bib55","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.schres.2009.12.001","article-title":"The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes","volume":"118","author":"M\u00fcller","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.emc.2013.09.001_bib56","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.drugalcdep.2011.01.012","article-title":"Synthetic cannabinoid JWH-018 and psychosis: an explorative study","volume":"117","author":"Every-Palmer","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.emc.2013.09.001_bib57","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jemermed.2010.10.014","article-title":"\u201cSpice\u201d girls: synthetic cannabinoid intoxication","volume":"40","author":"Schneir","year":"2011","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.emc.2013.09.001_bib58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s13181-011-0182-2","article-title":"Convulsions associated with the use of a synthetic cannabinoid product","volume":"8","author":"Schneir","year":"2012","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib59","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/ADM.0b013e3182619004","article-title":"Internet highs \u2013 seizures after consumption of synthetic cannabinoids purchased online","volume":"6","author":"Tofighi","year":"2012","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.emc.2013.09.001_bib60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MAJ.0b013e31824cf5c2","article-title":"Spicy seizure","volume":"344","author":"Pant","year":"2012","journal-title":"Am J Med Sci"},{"issue":"6","key":"10.1016\/j.emc.2013.09.001_bib61","doi-asserted-by":"crossref","first-page":"e1622","DOI":"10.1542\/peds.2010-3823","article-title":"Myocardial infarction associated with use of the synthetic cannabinoid K2","volume":"128","author":"Mir","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.emc.2013.09.001_bib62","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.annemergmed.2010.08.039","article-title":"Intoxication from smoking \u201cSpice\u201d","volume":"57","author":"Simmons","year":"2011","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.emc.2013.09.001_bib63","first-page":"93","article-title":"Acute kidney injury associated with synthetic cannabinoid use \u2013 multiple states 2012","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.emc.2013.09.001_bib64","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13181-013-0288-9","article-title":"High times, low sats: diffuse pulmonary infiltrates associated with chronic synthetic cannabinoid use","volume":"9","author":"Alhadi","year":"2013","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnbeh.2011.00060","article-title":"Beyond THC: the new generation of cannabinoid designer drugs","volume":"5","author":"Fattore","year":"2011","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.emc.2013.09.001_bib66","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3109\/15563650.2012.746424","article-title":"2011 annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 29th annual report","volume":"50","author":"Bronstein","year":"2012","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib67","doi-asserted-by":"crossref","first-page":"E2657","DOI":"10.1073\/pnas.1206820109","article-title":"Persistent cannabis users show neuropsychological decline from childhood to midlife","volume":"109","author":"Meier","year":"2012","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.emc.2013.09.001_bib68","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1097\/00004583-199612000-00013","article-title":"Case study: withdrawal syndrome in adolescent chronic cannabis users","volume":"35","author":"Duffy","year":"1996","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.emc.2013.09.001_bib69","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s11920-005-0036-1","article-title":"The marijuana withdrawal syndrome: diagnosis and treatment","volume":"7","author":"Haney","year":"2005","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.emc.2013.09.001_bib70","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/ADM.0b013e31828e1881","article-title":"The synthetic cannabinoid withdrawal syndrome","volume":"7","author":"Nacca","year":"2013","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.emc.2013.09.001_bib71","first-page":"464","article-title":"Withdrawal phenomena and dependence syndrome after the consumption of \u201cSpice Gold\u201d","volume":"106","author":"Zimmermann","year":"2009","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.emc.2013.09.001_bib72","unstructured":"National Medical Services (NMS) labs. NMS Labs Online Test Catalog. 2013. Available at: http:\/\/www.nmslabs.com\/test-catalog\/synthetic%20cannabinoids@0. Accessed June 10, 2013."},{"key":"10.1016\/j.emc.2013.09.001_bib73","series-title":"Assessment of khat (Catha edulis Forsk). 34th ECDD","author":"World Health Organization Expert Committee on Drug Dependence","year":"2006"},{"key":"10.1016\/j.emc.2013.09.001_bib74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13181-011-0193-z","article-title":"The toxicology of bath salts: a review of synthetic cathinones","volume":"8","author":"Prosser","year":"2012","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib75","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1365-2125.1990.tb05447.x","article-title":"Amphetamine-like effects in humans of the khat alkaloid cathinone","volume":"30","author":"Brenneisen","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.emc.2013.09.001_bib76","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4065\/mcp.2010.0398","article-title":"Association of khat chewing with increased risk of stroke and death in patients presents with acute coronary syndrome","volume":"85","author":"Ali","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.emc.2013.09.001_bib77","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1021\/ja01395a032","article-title":"Synthetic homologs of D,L-ephedrine","volume":"50","author":"Hyde","year":"1928","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.emc.2013.09.001_bib78","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/S0196-0644(05)80419-6","article-title":"Methcathinone: a Russian designer amphetamine infiltrates the rural Midwest","volume":"22","author":"Emerson","year":"1993","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.emc.2013.09.001_bib79","unstructured":"Mehta MB. United States patent 3,819,706: Meta-chloro substituted \u03b1-butylamino-propiophenones. United States Patent and Trademark Office (USPTO). 1974. Available at: http:\/\/patimg1.uspto.gov\/.piw?Docid=03819706&homeurl=http%3A%2F%2Fpatft.uspto.gov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO1%2526Sect2%3DHITOFF%2526d%3DPALL%2526p%3D1%2526u%3D%25252Fnetahtml%25252FPTO%25252Fsrchnum.htm%2526r%3D1%2526f%3DG%2526l%3D50%2526s1%3D3819706.PN.%2526OS%3DPN%2F3819706%2526RS%3DPN%2F3819706&PageNum=&Rtype=&SectionNum=&idkey=NONE&Input=View+first+page. Accessed June 13, 2013."},{"key":"10.1016\/j.emc.2013.09.001_bib80","unstructured":"United States Drug Enforcement Administration. Methcathinone. 2013. Available at: http:\/\/www.justice.gov\/dea_old\/concern\/methcathinone.html. Accessed June 13, 2013."},{"key":"10.1016\/j.emc.2013.09.001_bib81","series-title":"Mephedrone","author":"Psychonaut Web Mapping Research Group","year":"2009"},{"key":"10.1016\/j.emc.2013.09.001_bib82","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/qjmed\/hcq134","article-title":"Mephedrone use and associated adverse effects in school and college\/university students before the UK legislation change","volume":"103","author":"Dargan","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.emc.2013.09.001_bib83","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1360-0443.2010.03130.x","article-title":"Mephedrone, new kid for the chop?","volume":"106","author":"Winstock","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.emc.2013.09.001_bib84","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.annemergmed.2012.12.017","article-title":"A\u00a09-state analysis of designer stimulant, \u201cbath salt, \u201d hospital visits reported to poison control centers","volume":"62","author":"Warrick","year":"2013","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.emc.2013.09.001_bib85","unstructured":"American Association of Poison Control Centers. Bath salts data. 2013. Available at: https:\/\/aapcc.s3.amazonaws.com\/files\/library\/Bath_Salts_Data_for_Website_5.31.2013.pdf. Accessed June 14, 2013."},{"key":"10.1016\/j.emc.2013.09.001_bib86","unstructured":"American Association of Poison Control Centers. Synthetic marijuana data. 2013. Available at: https:\/\/aapcc.s3.amazonaws.com\/files\/library\/Synthetic_Marijuana_Data_for_Website_5.31.2013.pdf. Accessed June 14, 2013."},{"key":"10.1016\/j.emc.2013.09.001_bib87","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(10)62021-1","article-title":"Mephedrone: still available and twice the price","volume":"376","author":"Winstock","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.emc.2013.09.001_bib88","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1016\/j.bmcl.2010.05.065","article-title":"An analysis of the \u2018legal high\u2019 mephedrone","volume":"20","author":"Gibbons","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.emc.2013.09.001_bib89","first-page":"57","article-title":"Notice of intent \u2013 scheduled of controlled substances: temporary placement of three synthetic cathinones into schedule I","volume":"44","author":"US Department of Justice DEA","year":"2011","journal-title":"Microgram Bulletin"},{"key":"10.1016\/j.emc.2013.09.001_bib90","unstructured":"112th Congress. S. 3190: Synthetic Drug Abuse Prevention Act of 2012. Sec 2. Addition of Synthetic Drugs to Schedule I of the Controlled Substances Act. Washington, DC: Library of Congress [May 16, 2012]. Available at: http:\/\/www.govtrack.us\/congress\/bills\/112\/s3190\/text. Accessed July 2, 2013."},{"key":"10.1016\/j.emc.2013.09.001_bib91","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/15563650.2011.615318","article-title":"Clinical toxicology of newer recreational drugs","volume":"49","author":"Hill","year":"2011","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib92","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jat\/bks136","article-title":"Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results","volume":"37","author":"Marinetti","year":"2013","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib93","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/emj.2010.096636","article-title":"Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service","volume":"28","author":"James","year":"2011","journal-title":"Emerg Med\u00a0J"},{"key":"10.1016\/j.emc.2013.09.001_bib94","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00213-010-2070-x","article-title":"Mephedrone (4-methylmethcathinone; \u2018meow-meow\u2019): chemical, pharmacological and clinical issues","volume":"214","author":"Schifano","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.emc.2013.09.001_bib95","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3109\/15563650.2010.531021","article-title":"Case series of individuals with analytically confirmed acute mephedrone toxicity","volume":"48","author":"Wood","year":"2010","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib96","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.toxlet.2012.03.009","article-title":"Synthetic cathinones: chemistry, pharmacology, and toxicology of a new class of designer drugs of abuse marketed as \u201cbath salts\u201d or \u201cplant food\u201d","volume":"211","author":"Coppola","year":"2012","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.emc.2013.09.001_bib97","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00213-013-2967-2","article-title":"Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of \u201cbath salts, \u201d produce opposite effects at the human dopamine transporter","volume":"227","author":"Cameron","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.emc.2013.09.001_bib98","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(99)00538-5","article-title":"Inhibition of plasma membrane monoamine transporters by \u03b2-ketoamphetamines","volume":"381","author":"Cozzi","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.emc.2013.09.001_bib99","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2006.11.075","article-title":"The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain","volume":"559","author":"Nagai","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.emc.2013.09.001_bib100","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00216-010-3636-5","article-title":"Beta-ketoamphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry","volume":"397","author":"Meyer","year":"2010","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.emc.2013.09.001_bib101","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11419-011-0111-8","article-title":"Recently abused \u03b2-keto derivatives of 3,4-methylenedioxyphenylalkylamines: a review of the metabolisms and toxicological analysis","volume":"29","author":"Zaitsu","year":"2011","journal-title":"Forensic Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib102","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/jms.1859","article-title":"Studies on the metabolism of the \u03b1-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high resolution MS and its detectability in urine by GC-MS","volume":"45","author":"Meyer","year":"2010","journal-title":"J\u00a0Mass Spectrom"},{"key":"10.1016\/j.emc.2013.09.001_bib103","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s13181-010-0018-5","article-title":"Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity","volume":"6","author":"Wood","year":"2010","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib104","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s13181-012-0243-1","article-title":"\u201cBath Salts\u201d and \u201cPlant Food\u201d products: the experience of one regional US Poison Center","volume":"9","author":"Murphy","year":"2013","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib105","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1136\/hrt.2010.209338","article-title":"Headshop heartache: acute mephedone \u2018meow\u2019 myocarditis","volume":"96","author":"Nicholson","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.emc.2013.09.001_bib106","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jat\/bkt001","article-title":"Postmortem tissue distribution of MDPV following lethal intoxication by \u201cBath Salts\u201d","volume":"37","author":"Wyman","year":"2013","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib107","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.genhosppsych.2012.06.005","article-title":"Excited delirium following the use of synthetic cathinones (bath salts)","volume":"34","author":"Penders","year":"2012","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.emc.2013.09.001_bib108","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s13181-012-0232-4","article-title":"Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification","volume":"8","author":"Thornton","year":"2012","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib109","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/1556-4029.12038","article-title":"Acute psychosis induced by bath salts: a case report with clinical and forensic implications","volume":"58","author":"Stoica","year":"2013","journal-title":"J\u00a0Forensic Sci"},{"key":"10.1016\/j.emc.2013.09.001_bib110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13181-011-0196-9","article-title":"Death following recreational use of designer drug \u201cBath Salts\u201d containing 3,4-methylenedioxypyrovalerone (MDPV)","volume":"8","author":"Murray","year":"2012","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib111","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5811\/westjem.2011.6.6782","article-title":"Bath salts: the ivory wave of trouble","volume":"13","author":"Olives","year":"2012","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.emc.2013.09.001_bib112","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s13181-011-0159-1","article-title":"Seizures and hyponatremia related to ethcathinone and methylone poisoning","volume":"8","author":"Boulanger-Gobeil","year":"2012","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib113","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1360-0443.2011.03502.x","article-title":"Mephedrone: use, subjective effects and health risk","volume":"106","author":"Winstock","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.emc.2013.09.001_bib114","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13181-011-0199-6","article-title":"Lethal serotonin syndrome after methylone and butylone ingestion","volume":"8","author":"Warrick","year":"2012","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib115","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.annemergmed.2012.11.021","article-title":"Compartment syndrome after \u201cBath Salts\u201d use: a case series","volume":"61","author":"Levine","year":"2012","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.emc.2013.09.001_bib116","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.annemergmed.2012.01.005","article-title":"Hyperthermia and multiorgan failure after abuse of \u201cBath Salts\u201d containing 3,4-methylenedioxypyrovalerone","volume":"60","author":"Borek","year":"2012","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.emc.2013.09.001_bib117","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/00003246-198611000-00011","article-title":"Hyperthermia associated with drug intoxication","volume":"14","author":"Rosenberg","year":"1986","journal-title":"Crit Care Med"},{"key":"10.1016\/j.emc.2013.09.001_bib118","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/j.forsciint.2010.07.014","article-title":"The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland","volume":"202","author":"Torrance","year":"2010","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.emc.2013.09.001_bib119","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/PAF.0b013e31827ab5da","article-title":"Sudden cardiac death associated with methylone use","volume":"34","author":"Carbone","year":"2013","journal-title":"Am J Forensic Med Pathol"},{"key":"10.1016\/j.emc.2013.09.001_bib120","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/anatox\/35.3.188","article-title":"Mephedrone (4-methylmethcathinone)-related deaths","volume":"35","author":"Maskell","year":"2011","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib121","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0022-3565(25)21220-4","article-title":"Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuse","volume":"279","author":"Sparago","year":"1996","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.emc.2013.09.001_bib122","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1523\/JNEUROSCI.18-20-08417.1998","article-title":"Reduced striatal dopamine transporter density in the abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428","volume":"18","author":"McCann","year":"1998","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.emc.2013.09.001_bib123","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/15563650.2013.768344","article-title":"Cross-reactivity studies and predictive modeling of \u201cBath Salts\u201d and other amphetamine-type stimulants with amphetamine screening immunoassays","volume":"51","author":"Petrie","year":"2013","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib124","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00216-012-6548-8","article-title":"Determination of 32 cathinone derivatives and other designer drugs in serum by comprehensive LC-QQQ-MS\/MS analysis","volume":"405","author":"Swortwood","year":"2013","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.emc.2013.09.001_bib125","unstructured":"National Medical Services (NMS) labs. NMS Labs Online Test Catalog. 2013. Available at: http:\/\/www.nmslabs.com\/test-catalog\/bath%20salts@0. Accessed June 18, 2013."},{"key":"10.1016\/j.emc.2013.09.001_bib126","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s13181-013-0295-x","article-title":"2C or Not 2C: phenethylamine designer drug review","volume":"9","author":"Dean","year":"2013","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib127","series-title":"PiHKAL - a chemical love story","author":"Shulgin","year":"1991"},{"key":"10.1016\/j.emc.2013.09.001_bib128","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1360-0443.2010.02948.x","article-title":"Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin","volume":"105","author":"Benzenh\u00f6fer","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.emc.2013.09.001_bib129","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1177\/0269881111431752","article-title":"4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects","volume":"26","author":"Caudevilla-G\u00e1lligo","year":"2012","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.emc.2013.09.001_bib130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1023\/B:PHAR.0000018600.03664.36","article-title":"A\u00a0new trend in drugs-of-abuse; the 2C series of phenethylamine designer drugs","volume":"26","author":"de Boer","year":"2004","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.emc.2013.09.001_bib131","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jat\/22.5.345","article-title":"2C-B: a new psychoactive phenethylamine recently discovered in Ecstasy tablets sold on the Swiss black market","volume":"22","author":"Giroud","year":"1998","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib132","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/00952990701202970","article-title":"\u201cResearch Chemicals\u201d: tryptamine and phenethylamine use among high-risk youth","volume":"43","author":"Sanders","year":"2008","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.emc.2013.09.001_bib133","first-page":"526","article-title":"A\u00a0case series of symptomatic patients, including one fatality, following 2C-E exposure","volume":"49","author":"Topeff","year":"2011","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib134","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/FTD.0b013e3181eea318","article-title":"Chemistry, pharmacology, and metabolism of emerging drugs of abuse","volume":"32","author":"Maurer","year":"2010","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.emc.2013.09.001_bib135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0306-3623(94)90035-3","article-title":"Alpha-adrenergic and 5-HT2-serotonergic effects of some beta-phenylethylamines on isolated rat thoracic aorta","volume":"25","author":"Saez","year":"1994","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.emc.2013.09.001_bib136","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tox.2004.07.004","article-title":"Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with\u00a0hepatocytes of six species including human","volume":"206","author":"Carmo","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.emc.2013.09.001_bib137","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/jms.1128","article-title":"Studies on the metabolism and toxicological detection of the designer drug 2,5-dimethoxy-4-methyl-\u03b2-phenethylamine (2C-D) in rat urine using gas chromatographic\/mass spectrometric techniques","volume":"41","author":"Theobald","year":"2006","journal-title":"J\u00a0Mass Spectrom"},{"key":"10.1016\/j.emc.2013.09.001_bib138","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bcp.2006.09.022","article-title":"Identification of monoamine oxidase and cytochrome P450 isoenzymes involved in the deamination of phenethylamine-derived designer drugs (2C-series)","volume":"73","author":"Theobald","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.emc.2013.09.001_bib139","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/NRL.0b013e3181a3cb53","article-title":"Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingestion","volume":"16","author":"Ambrose","year":"2010","journal-title":"Neurologist"},{"key":"10.1016\/j.emc.2013.09.001_bib140","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s13181-013-0287-x","article-title":"Recurrent seizures and serotonin syndrome following \u201c2C-I\u201d ingestion","volume":"9","author":"Bosak","year":"2013","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib141","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/15563650.2011.572076","article-title":"The clinical toxicology of the designer \u201cparty pills\u201d benzylpiperazine and trifluoromethylphenylpiperazine","volume":"49","author":"Schep","year":"2011","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib142","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(07)60646-1","article-title":"Piperazine designer drugs of abuse","volume":"369","author":"Staack","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.emc.2013.09.001_bib143","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/qjmed\/hcq056","article-title":"Purchasing \u2018legal highs\u2019 on the Internet \u2013 is there consistency in what you get?","volume":"103","author":"Davies","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.emc.2013.09.001_bib144","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/09595230801956140","article-title":"Patterns of benzylpiperazine\/trifluoromethylphenylpiperazine party pill use and adverse effects in a population sample in New Zealand","volume":"27","author":"Wilkins","year":"2008","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.emc.2013.09.001_bib145","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/15563650802307602","article-title":"Toxicity from the recreational use of 1-benzylpiperazine","volume":"46","author":"Gee","year":"2008","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib146","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1196\/annals.1316.024","article-title":"Effects of \u201cLegal X\u201d piperazine analogs on dopamine and serotonin release in rat brain","volume":"1025","author":"Baumann","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.emc.2013.09.001_bib147","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.npp.1300585","article-title":"N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or \u2018Ecstasy\u2019)","volume":"30","author":"Baumann","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.emc.2013.09.001_bib148","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.drugalcdep.2011.10.007","article-title":"Piperazine compounds as drugs of abuse","volume":"122","author":"Arbo","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.emc.2013.09.001_bib149","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00558280","article-title":"A\u00a0comparison of the effects of 1-benzylpiperazine and dexamphetamine on human performance tests","volume":"6","author":"Bye","year":"1973","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.emc.2013.09.001_bib150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0379-0738(01)00452-2","article-title":"Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market","volume":"121","author":"de Boer","year":"2001","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.emc.2013.09.001_bib151","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/15563651003592948","article-title":"Multiorgan failure from 1-benyzlpiperazine ingestion \u2013 legal high or lethal high?","volume":"48","author":"Gee","year":"2010","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib152","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.drugpo.2009.02.005","article-title":"Differences in harm from legal BZP\/TFMPP party pills between North Island and South Island users in New Zealand: a case of effective industry self-regulation?","volume":"21","author":"Wilkins","year":"2010","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.emc.2013.09.001_bib153","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(07)60674-6","article-title":"Collapse, reported seizure \u2013 and an unexpected pill","volume":"369","author":"Wood","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.emc.2013.09.001_bib154","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1055\/s-2001-15702","article-title":"Fatal brain edema after ingestion of ecstasy and benzylpiperazine","volume":"126","author":"Balmelli","year":"2001","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.emc.2013.09.001_bib155","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jat\/32.2.172","article-title":"Investigation of the first deaths in the United Kingdom involving the detection and quantification of the piperazines BZP and 3-TFMPP","volume":"32","author":"Elliott","year":"2008","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib156","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0378-8741(89)90053-6","article-title":"Ethnopharmacology of Kratom and the mitragyna alkaloids","volume":"25","author":"Shellard","year":"1989","journal-title":"J\u00a0Ethnopharmacol"},{"key":"10.1016\/j.emc.2013.09.001_bib157","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/10550490701525368","article-title":"Self-treatment of opioid withdrawal with a dietary supplement, Kratom","volume":"16","author":"Boyer","year":"2007","journal-title":"Am J Addict"},{"key":"10.1016\/j.emc.2013.09.001_bib158","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0024-3205(98)00075-7","article-title":"Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice","volume":"62","author":"Thongpradichote","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.emc.2013.09.001_bib159","first-page":"21","article-title":"A\u00a0study of Kratom eaters in Thailand","volume":"27","author":"Suwanlert","year":"1975","journal-title":"Bull Narc"},{"key":"10.1016\/j.emc.2013.09.001_bib160","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s13181-010-0079-5","article-title":"Seizures and coma following Kratom (Mitragynina speciosa Korth) exposure","volume":"6","author":"Nelson","year":"2010","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib161","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/anatox\/35.4.242","article-title":"Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend Krypton","volume":"35","author":"Kronstrand","year":"2011","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.emc.2013.09.001_bib162","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/02791072.2011.566500","article-title":"Legally tripping: a qualitative profile of Salvia divinorum use among young adults","volume":"43","author":"Kelly","year":"2011","journal-title":"J\u00a0Psychoactive Drugs"},{"key":"10.1016\/j.emc.2013.09.001_bib163","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.drugalcdep.2010.05.003","article-title":"Use patterns and self-reported effects of Salvia divinorum: an internet-based survey","volume":"111","author":"Baggott","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.emc.2013.09.001_bib164","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/00498250902769967","article-title":"In\u00a0vitro stability and metabolism of Salvinorin A in rat plasma","volume":"39","author":"Tsujikawa","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.emc.2013.09.001_bib165","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jemermed.2009.05.019","article-title":"Salvia divinorum: exposures reported to a statewide poison control system over 10 years","volume":"40","author":"Rais","year":"2011","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.emc.2013.09.001_bib166","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1176\/appi.ajp.2009.08121759","article-title":"Persistent psychosis associated with Salvia divinorum use","volume":"166","author":"Przekop","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.emc.2013.09.001_bib167","first-page":"36","article-title":"Toxins of higher fungi","volume":"38","author":"Hatfield","year":"1975","journal-title":"Lloydia"},{"key":"10.1016\/j.emc.2013.09.001_bib168","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0196-0644(85)80643-0","article-title":"Intravenous mushroom poisoning","volume":"14","author":"Curry","year":"1985","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.emc.2013.09.001_bib169","doi-asserted-by":"crossref","first-page":"972.e3","DOI":"10.1016\/j.ajem.2008.01.058","article-title":"Unrecognized magic mushroom abuse in a 28-year-old man","volume":"26","author":"McClintock","year":"2008","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.emc.2013.09.001_bib170","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.drugalcdep.2012.11.010","article-title":"A\u00a0survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students","volume":"130","author":"Hallock","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.emc.2013.09.001_bib171","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.forsciint.2009.11.017","article-title":"Two cases of lysergamide intoxication by ingestion of seeds from Hawaiian baby woodrose","volume":"197","author":"Klinke","year":"2010","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.emc.2013.09.001_bib172","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.forsciint.2010.06.030","article-title":"\u201cLegal highs\u201d on the net: evaluation of UK-based websites, products and product information","volume":"206","author":"Schmidt","year":"2011","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.emc.2013.09.001_bib173","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.forsciint.2011.06.025","article-title":"Variable adverse effects in subjects after ingestion of equal doses of Argyreia nervosa seeds","volume":"214","author":"Kremer","year":"2012","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.emc.2013.09.001_bib174","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/02791072.2013.763570","article-title":"Recreational use of D-lysergamide from the seeds of Argyreia nervosa, Ipomoea tricolor, Ipomoea violacea, and Ipomoea purpurea in Poland","volume":"45","author":"Juszczak","year":"2013","journal-title":"J\u00a0Psychoactive Drugs"},{"key":"10.1016\/j.emc.2013.09.001_bib175","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.mcna.2005.06.002","article-title":"Toxin-induced hyperthermic syndromes","volume":"89","author":"Rusyniak","year":"2005","journal-title":"Med Clin North Am"}],"container-title":["Emergency Medicine Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862713000813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862713000813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T17:04:58Z","timestamp":1746032698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733862713000813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":175,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0733862713000813"],"URL":"https:\/\/doi.org\/10.1016\/j.emc.2013.09.001","relation":{},"ISSN":["0733-8627"],"issn-type":[{"value":"0733-8627","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}